Forbes Medi-Tech Inc.
OTC Bulletin Board : FMTI

January 18, 2007 08:01 ET

Forbes Medi-Tech Expands Reducol'TM' Sales in Portugal With the Addition of Modelo Continente to Customer List

Reducol'TM' Based Products Sold Through Country's Leading Retailers

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Jan. 18, 2007) - Forbes Medi-Tech Inc. (TSX:FMI)(NASDAQ:FMTI) today announced the expansion of Reducol™-based products in Portugal through one of its largest food retailers, Modelo Continente. The cholesterol-lowering ingredient will be featured in a range of dairy products including a Strawberry Flavor Yogurt Drink, Original Flavor Yogurt Drink, UHT Milk and Dairy Spread. The products will be marketed under the Modelo Continente private-label brand.

"Retailers such as Modelo Continente recognize the importance of maintaining their customers' loyalty by offering new, healthy, great tasting products," said Jeff Motley, VP Marketing and Sales at Forbes Medi-Tech. "The proven Reducol™ platform of solid science and top technology was a key factor in Modelo Continente's decision to launch the Reducol™ range of products. Their presence and stature will help establish a stronghold for the Reducol™ brand in the Portuguese marketplace."

The product lines of cholesterol-lowering dairy products containing Reducol™ are part of a growing trend in Europe. Portugal is the fifth country to recognize and adopt Reducol™ as a leading ingredient for cholesterol-lowering products. Forbes Medi-Tech has Reducol™ private-labeled products in the UK, The Netherlands, Finland, France and Portugal.

"Reducol™'s clinical studies, technology and health claims provided Modelo Continente with an opportunity to enter the intensely competitive cholesterol-lowering category with a private label product," said Mario Karim, Director at Modelo Continente. "We see Reducol™ as an important part of our healthy-choice products for consumers."

In Europe, Reducol™ can now be found in such dairy products as yogurt, yogurt drinks, cheese and margarine spread, but can also be found in items worldwide such as chocolate truffles and dietary supplements.

About Modelo Continente

Modelo Continente is a sub-holding of Sonae Group, the biggest Portuguese private company. Modelo Continente is a reference on the alimentation sector and is the first Portuguese hypermarket. The Group owns: Modelo and Continente hypermarkets, and Modelo Bounjour supermarkets.

About Reducol™

Reducol™ is a unique ingredient containing plant sterols and stanols, commonly known as phytosterols, or "Sterols". The combination of a prudent diet and consumption of products containing the recommended amount of Reducol™ may help consumers lower their cholesterol by up to 24%. Additional information on Reducol™ can be found at

About Forbes Medi-Tech Inc.

Forbes Medi-Tech Inc. is a life sciences company dedicated to the research, development and commercialization of innovative products for the prevention and treatment of cardiovascular disease (CVD). Our vision is to develop and market products along a treatment continuum that CVD savvy consumers, healthcare professionals and specialized CVD research and healthcare institutions will identify, recommend and seek. Our business strategy is to develop and commercialize proprietary compounds to address the unmet needs of patients within the cardiovascular disease market.

Forbes Medi-Tech ("Forbes" or the "Company") has relied solely on Modelo Continente for the information about Modelo Continente provided in this News Release and the Company disclaims any liability with respect to such information. Forbes disclaims responsibility for information contained in any linked or referenced website, and such links and references do not constitute an endorsement by Forbes of those or any other website. This News Release contains forward-looking statements regarding Reducol™, products containing Reducol™, and the Company's strategy and vision, which statements can be identified by the use of forward-looking terminology such as "will", "growing", "opportunity", "further", "future", "strategy", "vision", "to develop" or comparable terminology referring to future events or results. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of numerous factors, including the Company's reliance on Fayrefield Foods and Modelo Continente for performance; the need to secure new customers which is not assured; uncertainty regarding market acceptance and demand for products containing Reducol™; uncertainty whether demand for Reducol™-based products will continue to grow; product development risks; intellectual property risks; manufacturing, marketing and supply risks; product liability and insurance risks; uncertainty as to future sales volumes and pricing; the effect of competition; the need for regulatory approvals, which are uncertain; changes in business strategy or development plans; exchange rate fluctuations; and the Company's need for future funding; as well as a description of other risks and uncertainties affecting the Company and its business, as contained in news releases and filings with Securities Regulatory Authorities in Canada and the U.S., any of which could cause actual results to vary materially from current results or the Company's anticipated future results. Forward-looking statements are based on the beliefs, opinions and expectations of the Company's management at the time they are made, and the Company does not assume any obligation to update any statement should those beliefs, opinions or expectations, or other circumstances change.

NASDAQ and the Toronto Stock Exchange have not reviewed and do not accept responsibility for the adequacy or accuracy of the content of this News Release.

Contact Information